underwent the laboratory tests, hepatic ultrasonography, and valid transient elastography (FibroScan) examination
You may not be if
other known chronic liver diseases, such as chronic hepatitis B or C, autoimmune hepatitis, and haemochromatosis
pre-existing active cancer, renal dysfunction, severe liver dysfunction, congestive heart failure or free abdominal fluid
history of hyperthyroidism or hypothyroidism, pituitary diseases, and other types of diabetes
significant alcohol consumption
pregnancy
receiving any therapeutic methods that could lead to liver steatosis or fibrosis, influence the glucolipid metabolism, or PRL levels, such as lipid-lowering, and PRL-lowering agents (bromocriptine) within 6 months prior to this study.
